Narita Hospital

Alternate names: 成田病院, 鳳生会総合医療センター成田病院

ROR: 00xawn257

OpenAlex ID: I4405283044

Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation

2016 · J Kanda, Y Morishima, et al. · Leukemia · 68

Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation

2017 · Takashi Kumagai, Chiaki Nakaseko, et al. · Cancer Science · 65

PDF

Revolutionizing Spinal Care: Current Applications and Future Directions of Artificial Intelligence and Machine Learning

2023 · Mitsuru Yagi, Kento Yamanouchi, et al. · Journal of Clinical Medicine · 64

PDF

Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy

2015 · Yasuyuki Arai, June Takeda, et al. · Blood · 64

The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles

2010 · B. Baasanjav, H. Usui, et al. · Human Reproduction · 61

Human Herpesvirus 6 Harbouring in Kidney

1989 · Yoshizo Asano, Tetsushi Yoshikawa, et al. · The Lancet · 52

Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance

2022 · Mina Komuta · Clinical and Molecular Hepatology · 50

PDF

Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010

2013 · Y. Muraki, M. Kitamura, et al. · Infection · 49

Diagnostic Efficacy of Tumor Markers, Sonography, and Intraoperative Frozen Section for Ovarian Tumors

2001 · Fumiyo Wakahara, Fumitaka Kikkawa, et al. · Gynecologic and Obstetric Investigation · 49

Aberrant DNA methylation of hypothalamic angiotensin receptor in prenatal programmed hypertension

2018 · Fumiko Kawakami-Mori, Mitsuhiro Nishimoto, et al. · JCI Insight · 48

PDF

Shorter halving time of BCR‐ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic‐phase chronic myeloid leukemia treated with dasatinib: Results of the D‐first study of K anto CML study group

2014 · Noriyoshi Iriyama, Shin Fujisawa, et al. · American Journal of Hematology · 48

Patients’ preferences and factors influencing initial advance care planning discussions’ timing: A cross-cultural mixed-methods study

2020 · Jun Miyashita, Ayako Kohno, et al. · Palliative Medicine · 43

Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response—The final results of the D-first study

2018 · Yuho Najima, Chikashi Yoshida, et al. · Leukemia Research · 39

Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission

2013 · J Tanaka, Y Morishima, et al. · Blood Cancer Journal · 39

PDF

Apoptosis-inducing factor deficiency decreases the proliferation rate and protects the subventricular zone against ionizing radiation

2010 · K Osato, Y Sato, et al. · Cell Death and Disease · 39

PDF

Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large‐scale multicenter retrospective study

2023 · Hideki Fujii, Yuichiro Suzuki, et al. · Hepatology Research · 38

Amyloid arthropathy of the hip joint: MR demonstration of presumed amyloid lesions in 152 patients with long-term hemodialysis

1998 · S. Otake, Y. Tsuruta, et al. · European Radiology · 36

Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D‐first study

2015 · Noriyoshi Iriyama, Shin Fujisawa, et al. · American Journal of Hematology · 35

PDF

Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature

2019 · Hirotoshi Kawashima, Atsunari Utsugi, et al. · Immunologic Research · 33

Harmonization of molecular monitoring of chronic myeloid leukemia therapy in Japan

2011 · Chikashi Yoshida, Linda Fletcher, et al. · International Journal of Clinical Oncology · 31

Granulocyte colony-stimulating factor combined regimen in cord blood transplantation for acute myeloid leukemia: a nationwide retrospective analysis in Japan

2014 · T. Konuma, J. Ooi, et al. · Haematologica · 29

PDF

Delayed neurological signs following isolated parasagittal injury in asphyxia at term

2007 · Yoshiaki Sato, Masahiro Hayakawa, et al. · European Journal of Paediatric Neurology · 26

Healthcare Providers’ Perceptions on the Timing of Initial Advance Care Planning Discussions in Japan: a Mixed-Methods Study

2021 · Jun Miyashita, Ayako Kohno, et al. · Journal of General Internal Medicine · 25

PDF

Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial

2024 · Jun Hamano, Takahiro Higashibata, et al. · Journal of Clinical Oncology · 24

Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia

2013 · Takashi Kumagai, Eri Matsuki, et al. · International Journal of Hematology · 24

Works count: 0

Citation count: